Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 6:01 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1441–1464 of 21,040 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ONE Clear all

Conditions: Panic Disorder
Interventions: Raise-CO2 breathing regulation training, Lower-CO2 breathing regulation training, Control; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 136 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Glioma
Interventions: Crenolanib (CP-868,596); Drug
Lead sponsor: Arog Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Facial Aging
Interventions: Laser Treatment; Procedure
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Lyndhurst, Ohio

Conditions: Improving Treatment for Opioid Use Disorder in Courts
Interventions: eLearning Modules, Change Team Intervention; Behavioral
Lead sponsor: National Development and Research Institutes, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 96 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Striae Distensae
Interventions: Poly-L Lactic Acid, Fractional laser treatment; Drug · Device
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Pregnancy Complications, Maternal Care Patterns, Patient Engagement
Interventions: Melanated Group Midwifery Care; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 15 Years to 49 Years · Female only
Enrollment: 432 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Parkinson Disease
Interventions: Pickleball program; Other
Lead sponsor: Midwestern University; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Prenatal Care, Maternal-child Health Services, Maternal Health Services, Perinatal Care, Midwifery
Interventions: Collaborative Care, Comparison Care- Usual Care + primary midwife; Behavioral
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Dry Age-related Macular Degeneration
Interventions: GT005; Drug
Lead sponsor: Gyroscope Therapeutics Limited; Industry
Eligibility: 55 Years and older
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 32
States / cities: Phoenix, Arizona • Huntington Beach, California • Palo Alto, California + 29 more

Conditions: Smoking
Interventions: Nicoderm patch first, then Aveva patch; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 45 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Emmetropia, Myopia
Interventions: White Light therapy, Blue light therapy, Red light therapy, Darkness; Other
Lead sponsor: University of Houston; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Prostate Cancer
Interventions: Proton Radiation, Proton; Radiation
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 167 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2019
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Acute Ischemic Stroke
Interventions: natalizumab, Placebo; Drug
Lead sponsor: Biogen; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 277 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 18
States / cities: Los Angeles, California • Sacramento, California • San Diego, California + 13 more

Conditions: Vaccine Response
Interventions: Live Attenuated Yellow Fever 17D Vaccine, Quadrivalent seasonal influenza vaccine; Biological
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 3
States / cities: Atlanta, Georgia • Decatur, Georgia

Conditions: Chronic Pain Patients, Medical Cannabis Users
Interventions: Cognitive testing, Task-based fMRI measure of face-name and verbal learning; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 30 Years to 75 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Prostate Cancer, Prostate Adenocarcinoma
Interventions: Sunphenon, Placebo; Drug
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older · Male only
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 2
States / cities: Tampa, Florida • Westwood, Kansas

Conditions: Diabetes Mellitus, Type 2, Obesity
Interventions: Usual medical care, Lifestyle Case management; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 20 Years to 60 Years
Enrollment: 147 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2003
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Carcinoma in Situ of Bladder, Bladder Cancer
Interventions: Durvalumab, Cystoscopy with Biopsy; Drug · Procedure
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 2
States / cities: Miami Beach, Florida • Tampa, Florida

Conditions: Resistance Training, Caffeine, Dietary Supplements
Interventions: Caffeinated pre-workout supplement, Non-caffeinated pre-workout supplement, Placebo; Dietary Supplement
Lead sponsor: Texas Tech University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Cerebrovascular Accident
Interventions: TR intervention, In-home messaging device., Usual care; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 45 Years to 90 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 3
States / cities: Decatur, Georgia • Indianapolis, Indiana • Durham, North Carolina

Conditions: Infection, Pregnancy
Interventions: Placebo, Probiotic dietary supplement; Drug · Dietary Supplement
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 251 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2017
U.S. locations: 3
States / cities: Aptos, California • Santa Cruz, California • Stanford, California

Conditions: Obesity, Pregnancy
Interventions: Weight Management, Usual Care; Behavioral · Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 118 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Crohn's Disease
Interventions: Rifaximin EIR, Placebo; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 78
States / cities: Huntsville, Alabama • Tucson, Arizona • Sherwood, Arkansas + 68 more

Conditions: Dental Caries in Children, Health Behavior, Healthcare Disparities
Interventions: Community Health Worker (CHW) services; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 6 Months to 36 Months
Enrollment: 420 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 13
States / cities: Blue Island, Illinois • Chicago, Illinois • Chicago Heights, Illinois + 5 more

Search by objective public record fields.

Breathing Regulation Training for Individuals With Panic Disorder

Study of Crenolanib, a Selective and Potent Inhibitor of PDGFR, for the Treatment of Adult Gliomas

Laser Spot Treatment of Perioral Rhytids

Facilitating MAT Acceptance & Implementation in Problem Solving & Felony Courts

Fractional Laser Assisted Delivery of Sculptra® for the Treatment of Striae

Melanated Group Midwifery Care (MGMC)

Feasibility and Effects of a Pickleball Program for People With Parkinson Disease

Collaboration for Antepartum Risk Evaluation

EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

Transdermal Patch CVD 1000: The Effect of Heat on Nicotine Release From Nicotine Patches in Adult Smokers

Effects of Light on the Choroid and Pupil

Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer

Safety and Efficacy of Intravenous Natalizumab in Acute Ischemic Stroke

Durability of Vaccine Responses

Medical Cannabis and Behavior

Clinical Trial of Green Tea Catechins in Men on Active Surveillance

Lifestyle Intervention's Impact on Health Care Costs

Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder

Influence of Caffeinated and Non-caffeinated Pre-workout Supplements on Resistance Exercise Performance

Home-based Telehealth Stroke Care: A Randomized Trial for Veterans

Effects of Oral Probiotic Supplementation on Group B Strep (GBS) Rectovaginal Colonization in Pregnancy

Weight Management for Improved Pregnancy Outcomes

One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease

Coordinated Oral Health Promotion (CO-OP) Chicago